Page last updated: 2024-08-21

cyclopentane and Sclerosis, Systemic

cyclopentane has been researched along with Sclerosis, Systemic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abedi, M; Chen, M; Khuat, LT; Murphy, WJ; Pai, CS	1

Other Studies

1 other study(ies) available for cyclopentane and Sclerosis, Systemic

Article	Year
Therapeutic Effects of a NEDD8-Activating Enzyme Inhibitor, Pevonedistat, on Sclerodermatous Graft-versus-Host Disease in Mice. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2017, Volume: 23, Issue:1 Topics: Animals; Antigen-Presenting Cells; Cyclopentanes; Enzyme Inhibitors; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Lymphoma, B-Cell; Mice; Pyrimidines; Scleroderma, Systemic; T-Lymphocytes; Time Factors; Transplantation, Homologous; Ubiquitin-Activating Enzymes	2017

Article

Year

Therapeutic Effects of a NEDD8-Activating Enzyme Inhibitor, Pevonedistat, on Sclerodermatous Graft-versus-Host Disease in Mice.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2017, Volume: 23, Issue:1

Topics: Animals; Antigen-Presenting Cells; Cyclopentanes; Enzyme Inhibitors; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Lymphoma, B-Cell; Mice; Pyrimidines; Scleroderma, Systemic; T-Lymphocytes; Time Factors; Transplantation, Homologous; Ubiquitin-Activating Enzymes

2017